Results 31 to 40 of about 56,599 (248)

Paradoxical worsening of nontuberculous mycobacterial disease after the discontinuation of antitumor necrosis factor therapy: A case report

open access: yesRespiratory Medicine Case Reports, 2022
Antitumor necrosis factor–associated nontuberculous mycobacteria-immune reconstitution inflammatory syndrome (IRIS) has rarely been reported. An 84-year-old woman with a history of rheumatoid arthritis treated with etanercept was diagnosed with ...
Daijiro Nabeya, Tomoo Kishaba
doaj   +1 more source

Biologic TNF-α Inhibitors for Stevens–Johnson Syndrome, Toxic Epidermal Necrolysis, and TEN-SJS Overlap: A Study-Level and Patient-Level Meta-Analysis

open access: yesDermatology and Therapy, 2023
Introduction Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe cutaneous adverse reactions with high morbidity and mortality and not clearly established treatment protocol.
Jiali Cao   +3 more
doaj   +1 more source

The Effect of Etanercept in Nonradiographic Axial Spondyloarthritis by Stratified C‐Reactive Protein Levels

open access: yes, 2021
Objective Biological agents have shown markedly different response rates by baseline C‐reactive protein (CRP). Here, we determine the response of patients with nonradiographic axial spondyloarthritis (nr‐axSpA) to etanercept stratified by their baseline ...
Tam, Hoi Ki Joshua   +5 more
core   +1 more source

Etanercept Attenuates Traumatic Brain Injury in Rats by Reducing Brain TNF-α Contents and by Stimulating Newly Formed Neurogenesis

open access: yesMediators of Inflammation, 2013
It remains unclear whether etanercept penetrates directly into the contused brain and improves the outcomes of TBI by attenuating brain contents of TNF-α and/or stimulating newly formed neurogenesis.
Chong-Un Cheong   +5 more
doaj   +1 more source

Nail Lichen Planus: Successful Treatment with Etanercept [PDF]

open access: yes, 2010
BACKGROUND: Etanercept is a fully human tumor necrosis factor a receptor fusion protein that binds tumor necrosis factor a with greater affinity than natural receptors.
Irla, N   +7 more
core   +1 more source

Etanercept ameliorate cardiac damage and Apoptosis Induced by Myocardial Ischemia/Reperfusion in male mice.

open access: yesKufa Journal for Veterinary Medical Sciences, 2014
Ischemia-reperfusion of cardiac tissues may lead to a prominent damage of the cardiomyocyte through either necrosis or apoptosis that seems to be the predominant modes of death during this period. In this study, we investigated the effects of Etanercept
Najah R. Hadi   +3 more
doaj   +1 more source

A case of postoperative nasopharyngeal reflux associated with retropharyngeal lymphangioma in newborn infant [PDF]

open access: yesKorean Journal of Pediatrics, 2010
Tumor necrosis factor-?#6184;TNF-?#6752;is a major proinflammatory cytokine involved in the pathophysiology of juvenile rheumatoid arthritis. Etanercept is an effective inhibitor of TNF-?#6177;nd has shown a beneficial effect in patients with JRA ...
Ah Reum Kwon   +3 more
doaj   +1 more source

TNF-α antagonist attenuates systemic lipopolysaccharide-induced brain white matter injury in neonatal rats

open access: yesBMC Neuroscience, 2019
Background Systemic inflammation is an important risk factor for neurodevelopmental impairments in preterm infants. Premyelinating oligodendrocytes are main building blocks of white matter in preterm infants and vulnerable to oxidative stress and ...
Seung Han Shin   +3 more
doaj   +1 more source

Inflammatory cascades driven by tumor necrosis factor-alpha play a major role in the progression of acute liver failure and its neurological complications. [PDF]

open access: yesPLoS ONE, 2012
Acute liver failure (ALF) due to ischemic or toxic liver injury is a clinical condition that results from massive loss of hepatocytes and may lead to hepatic encephalopathy (HE), a serious neuropsychiatric complication.
Anne Chastre   +5 more
doaj   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy